ES8102121A1 - Procedimiento para la preparacion de anilidas de acido-4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilico - Google Patents

Procedimiento para la preparacion de anilidas de acido-4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilico

Info

Publication number
ES8102121A1
ES8102121A1 ES486536A ES486536A ES8102121A1 ES 8102121 A1 ES8102121 A1 ES 8102121A1 ES 486536 A ES486536 A ES 486536A ES 486536 A ES486536 A ES 486536A ES 8102121 A1 ES8102121 A1 ES 8102121A1
Authority
ES
Spain
Prior art keywords
pyrimidine
amino
carbanilides
preparation
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES486536A
Other languages
English (en)
Spanish (es)
Other versions
ES486536A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES486536A0 publication Critical patent/ES486536A0/es
Publication of ES8102121A1 publication Critical patent/ES8102121A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
ES486536A 1978-12-09 1979-12-03 Procedimiento para la preparacion de anilidas de acido-4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilico Expired ES8102121A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782853220 DE2853220A1 (de) 1978-12-09 1978-12-09 Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung

Publications (2)

Publication Number Publication Date
ES486536A0 ES486536A0 (es) 1980-12-16
ES8102121A1 true ES8102121A1 (es) 1980-12-16

Family

ID=6056720

Family Applications (3)

Application Number Title Priority Date Filing Date
ES486536A Expired ES8102121A1 (es) 1978-12-09 1979-12-03 Procedimiento para la preparacion de anilidas de acido-4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilico
ES491225A Expired ES8101069A1 (es) 1978-12-09 1980-05-07 Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
ES491224A Granted ES491224A0 (es) 1978-12-09 1980-05-07 Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES491225A Expired ES8101069A1 (es) 1978-12-09 1980-05-07 Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
ES491224A Granted ES491224A0 (es) 1978-12-09 1980-05-07 Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos

Country Status (9)

Country Link
US (1) US4285946A (enExample)
EP (1) EP0012361B1 (enExample)
JP (1) JPS5581863A (enExample)
AT (1) ATE1288T1 (enExample)
AU (1) AU529426B2 (enExample)
CA (1) CA1136623A (enExample)
DE (2) DE2853220A1 (enExample)
ES (3) ES8102121A1 (enExample)
ZA (1) ZA796651B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436911A (en) * 1981-05-12 1984-03-13 William H. Rorer, Inc. Heterocyclic amidinoureas
JPS58501468A (ja) * 1981-08-24 1983-09-01 ロウラ−　インタ−ナシヨナル　（オ−バ−シ−ズ）　インコ−ポレ−テツド 複素環アミジノ置換尿素およびそれらの薬剤利用
DE3522940A1 (de) * 1985-06-27 1987-01-08 Hoechst Ag 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaeure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln
ES2098570T3 (es) * 1992-02-22 1997-05-01 Hoechst Ag Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
ATE158581T1 (de) * 1992-02-22 1997-10-15 Hoechst Ag Lösliche salze von 4-amino-2-(4,4-dimethyl- imidazolidin-2-on-1-yl)-pyrimidin-5 -carbonsäure- n-methyl-n-(3-trifluormethyl-phenyl)- amid, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und ausgangsprodukte
DE19625088A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19625089A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
ATE314362T1 (de) * 1999-10-12 2006-01-15 Takeda Pharmaceutical Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung
US7176310B1 (en) * 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
US8193206B2 (en) * 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
EA015890B1 (ru) * 2005-06-14 2011-12-30 Тайджен Байотекнолоджи Ко. Лтд. Производные пиримидина
AU2009225869B2 (en) 2008-03-18 2014-01-23 Merck Sharp & Dohme Llc Substituted 4-hydroxypyrimidine-5-carboxamides
JP5317263B2 (ja) * 2008-09-24 2013-10-16 株式会社ユニバーサルエンターテインメント 紙葉類処理装置
CN104125947A (zh) * 2011-12-21 2014-10-29 生物区欧洲有限公司 杂环脲化合物
WO2016161268A1 (en) 2015-04-01 2016-10-06 Enanta Pharmaceuticals, Inc. Hepatitis b antviral agents
US10738035B2 (en) * 2015-05-13 2020-08-11 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017011552A1 (en) 2015-07-13 2017-01-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017136403A1 (en) 2016-02-02 2017-08-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
KR102398439B1 (ko) 2016-03-07 2022-05-16 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
EP3468561A4 (en) 2016-06-10 2019-12-04 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
SG11202001685TA (en) 2017-08-28 2020-03-30 Enanta Pharm Inc Hepatitis b antiviral agents
US10723733B2 (en) 2017-12-06 2020-07-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2019113173A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US10729688B2 (en) 2018-03-29 2020-08-04 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
TW202024093A (zh) 2018-09-21 2020-07-01 美商安塔製藥公司 作為抗病毒劑之官能化雜環
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
US11802125B2 (en) 2020-03-16 2023-10-31 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031265A (en) * 1963-11-12 1966-06-02 Geigy Co Ltd Tri-tertiary aminopyrimidines and their production
US3479357A (en) * 1967-10-20 1969-11-18 Searle & Co (6 - phenylpyrimidine)mono/bis(1h - 1,2,3-triazole- 4,5-dicarboxylic acid) lower alkyl esters

Also Published As

Publication number Publication date
ES8101068A1 (es) 1980-12-01
ES491224A0 (es) 1980-12-01
JPS5581863A (en) 1980-06-20
US4285946A (en) 1981-08-25
JPH0457675B2 (enExample) 1992-09-14
EP0012361A1 (de) 1980-06-25
EP0012361B1 (de) 1982-06-30
ES491225A0 (es) 1980-12-01
CA1136623A (en) 1982-11-30
ZA796651B (en) 1981-05-27
ATE1288T1 (de) 1982-07-15
ES486536A0 (es) 1980-12-16
DE2963278D1 (en) 1982-08-19
DE2853220A1 (de) 1980-07-03
AU5357179A (en) 1980-06-12
ES8101069A1 (es) 1980-12-01
AU529426B2 (en) 1983-06-09

Similar Documents

Publication Publication Date Title
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
ES8402560A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
IL61333A0 (en) Secondary amines, their preparation and pharmaceutical compositions containing them
ES8101884A1 (es) Procedimiento de obtencion de composiciones cosmeticas
SE8405588D0 (sv) New compounds
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES2001389A6 (es) Procedimiento para preparar derivados de o-toluidina
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
DE2966706D1 (en) Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
DE3660764D1 (en) Triazole derivatives, process for their preparation and pharmaceutical compositions containing them
ES8201521A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido propanoico
IE810901L (en) Naphthotriazoles.
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
MY8500167A (en) Novel indane derivatives process for their preparation their use as pharmaceuticals and pharmaceutical compositions containing said derivatives
DE2965783D1 (en) Monochlorcitric acid derivatives, pharmaceutical compositions containing them and process for the preparation of these derivatives
ES8101578A1 (es) Procedimiento para la obtencion de un derivado del aldehido 3,4-dihidroxicinamico
ES8502128A1 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301